Core Capex To Revenue from 2010 to 2024

CORZ Stock  USD 17.71  0.59  3.45%   
Core Scientific, Capex To Revenue yearly trend continues to be fairly stable with very little volatility. Capex To Revenue will likely drop to 0.03 in 2024. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.0321676
Current Value
0.0306
Quarterly Volatility
0.26462803
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Core Scientific, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core Scientific,'s main balance sheet or income statement drivers, such as Tax Provision of 645.4 K, Depreciation And Amortization of 116.5 M or Interest Expense of 63.8 M, as well as many indicators such as Price To Sales Ratio of 3.06, Dividend Yield of 0.0 or Days Sales Outstanding of 5.46. Core financial statements analysis is a perfect complement when working with Core Scientific, Valuation or Volatility modules.
  
Check out the analysis of Core Scientific, Correlation against competitors.

Latest Core Scientific,'s Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of Core Scientific, Common over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Core Scientific,'s Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Core Scientific,'s overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Slightly volatile
   Capex To Revenue   
       Timeline  

Core Capex To Revenue Regression Statistics

Arithmetic Mean0.47
Geometric Mean0.30
Coefficient Of Variation56.04
Mean Deviation0.23
Median0.63
Standard Deviation0.26
Sample Variance0.07
Range0.6025
R-Value(0.71)
Mean Square Error0.04
R-Squared0.51
Significance0
Slope(0.04)
Total Sum of Squares0.98

Core Capex To Revenue History

2024 0.0306
2023 0.0322
2022 0.6
2021 0.11
2020 0.026

About Core Scientific, Financial Statements

Core Scientific, investors use historical fundamental indicators, such as Core Scientific,'s Capex To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Core Scientific,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capex To Revenue 0.03  0.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Core Stock Analysis

When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.